These Money Losses Won't Help You at Tax Time
How to Save and Invest for a House Down Payment
5 Signs You Have a Spending Problem
Are Kohl's and T.J. Maxx Being Honest About Pricing?
Is Celgene the Perfect Stock?
Merck has confirmed that it halted its late-stage student of vorapaxar, a potential clot-preventing drug, after an increased risk of bleeding in some patients.